TELA Bio (TELA) Fundamental Analysis: Revenue, Earnings & Valuation

0.41 / 10

Underperform

Fundamental health is poor, scoring 0.4/10. Asset‑MV and Profit‑MV show modest strength, yet Cash‑MV, Cash‑UP and ROE are markedly negative, dragging performance. Net‑profit‑to‑total‑profit ratio is high but offers no offset to the overall weak fundamentals.

Analysis Checks(4/10)

ROA (%)

Value-40.21

Score1/3

Weight9.62%

1M Return-1.19%

Annualized return on equity (%)

Value-264.67

Score0/3

Weight33.60%

1M Return-5.73%

Profit-MV

Value0.41

Score2/3

Weight-32.14%

1M Return3.26%

Cash-UP

Value-0.01

Score2/3

Weight29.31%

1M Return-3.92%

Annualized net profit margin on total assets (%)

Value-53.62

Score1/3

Weight9.62%

1M Return-1.19%

ROE (diluted) (%)

Value-1913.29

Score0/3

Weight35.30%

1M Return-5.82%

Asset-MV

Value-0.48

Score3/3

Weight-51.86%

1M Return4.79%

ROE (%)

Value-198.50

Score0/3

Weight33.60%

1M Return-5.73%

Cash-MV

Value-0.09

Score1/3

Weight25.27%

1M Return-3.56%

Net profit / Total profit (%)

Value100.29

Score2/3

Weight7.68%

1M Return-0.89%

Is TELA undervalued or overvalued?

TELA scores 0.41/10 on fundamentals and holds a Premium valuation at present. Backed by its -198.50% ROE, -50.61% net margin, -0.74 P/E ratio, 19.37 P/B ratio, and 50.89% earnings growth, these metrics solidify its Underperform investment rating.